Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis A | 2 | 2018 | 140 | 0.75 | Why? |
| Platelet Factor 4 | 1 | 2021 | 385 | 0.68 | Why? |
| Antibodies, Anticardiolipin | 1 | 2018 | 208 | 0.66 | Why? |
| Sexually Transmitted Diseases, Viral | 1 | 2017 | 115 | 0.60 | Why? |
| Hepatitis B Vaccines | 1 | 2017 | 245 | 0.58 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.56 | Why? |
| Antibodies | 1 | 2021 | 846 | 0.56 | Why? |
| Blood Proteins | 1 | 2018 | 551 | 0.55 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2021 | 846 | 0.53 | Why? |
| Autoantibodies | 3 | 2021 | 2094 | 0.52 | Why? |
| Leukocyte Count | 2 | 2021 | 3178 | 0.52 | Why? |
| Orthomyxoviridae | 1 | 2021 | 1168 | 0.47 | Why? |
| Homosexuality, Male | 3 | 2018 | 1158 | 0.47 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.44 | Why? |
| Monocytes | 2 | 2021 | 2978 | 0.38 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.35 | Why? |
| Sexual and Gender Minorities | 1 | 2017 | 1019 | 0.34 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.25 | Why? |
| ADAM Proteins | 1 | 2021 | 43 | 0.22 | Why? |
| Culture Media | 2 | 2019 | 366 | 0.21 | Why? |
| Proteoglycans | 1 | 2021 | 130 | 0.21 | Why? |
| Microbiological Techniques | 2 | 2019 | 232 | 0.21 | Why? |
| Nasal Obstruction | 1 | 2020 | 131 | 0.20 | Why? |
| Cystic Fibrosis | 2 | 2020 | 1104 | 0.19 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.19 | Why? |
| Supervised Machine Learning | 1 | 2020 | 172 | 0.19 | Why? |
| Bacteriological Techniques | 2 | 2019 | 239 | 0.18 | Why? |
| Decision Trees | 1 | 2020 | 441 | 0.18 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.18 | Why? |
| Urinary Catheterization | 1 | 2018 | 47 | 0.18 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2020 | 214 | 0.17 | Why? |
| Hepatitis A Vaccines | 1 | 2018 | 52 | 0.17 | Why? |
| Factor X | 1 | 2017 | 18 | 0.17 | Why? |
| Scavenger Receptors, Class A | 1 | 2017 | 26 | 0.17 | Why? |
| Bronchial Fistula | 1 | 2017 | 28 | 0.17 | Why? |
| Factor X Deficiency | 1 | 2017 | 17 | 0.17 | Why? |
| Interferon Type I | 2 | 2021 | 2789 | 0.17 | Why? |
| Evaluation Studies as Topic | 1 | 2019 | 391 | 0.17 | Why? |
| Azabicyclo Compounds | 1 | 2018 | 91 | 0.17 | Why? |
| Catheters, Indwelling | 1 | 2018 | 84 | 0.17 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.17 | Why? |
| Microbiology | 1 | 2019 | 134 | 0.16 | Why? |
| Ceftazidime | 1 | 2018 | 134 | 0.16 | Why? |
| Tuberculosis, Miliary | 1 | 2017 | 66 | 0.16 | Why? |
| Metabolome | 1 | 2021 | 624 | 0.16 | Why? |
| Neoplasm Proteins | 1 | 2021 | 501 | 0.15 | Why? |
| Environmental Pollution | 1 | 2019 | 344 | 0.15 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.14 | Why? |
| Enterobacteriaceae Infections | 1 | 2020 | 529 | 0.14 | Why? |
| Nerve Tissue Proteins | 1 | 2017 | 319 | 0.14 | Why? |
| France | 6 | 2020 | 12074 | 0.13 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.13 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.13 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.13 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.13 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.13 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 13720 | 0.13 | Why? |
| Clinical Laboratory Services | 1 | 2019 | 781 | 0.12 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.12 | Why? |
| Mouth | 1 | 2017 | 622 | 0.12 | Why? |
| Antiphospholipid Syndrome | 1 | 2018 | 533 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.11 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.11 | Why? |
| Aged | 13 | 2021 | 215776 | 0.11 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.11 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.11 | Why? |
| Male | 18 | 2021 | 367725 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Equipment Contamination | 1 | 2019 | 1308 | 0.10 | Why? |
| Blood Platelets | 1 | 2021 | 1704 | 0.10 | Why? |
| Adult | 13 | 2021 | 244371 | 0.10 | Why? |
| Disinfection | 2 | 2020 | 2912 | 0.10 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.10 | Why? |
| Sexually Transmitted Diseases | 1 | 2017 | 694 | 0.10 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.10 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.10 | Why? |
| Humans | 34 | 2021 | 930598 | 0.09 | Why? |
| Lung Transplantation | 1 | 2020 | 1554 | 0.09 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.09 | Why? |
| Female | 15 | 2021 | 380317 | 0.09 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.09 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.09 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2018 | 1380 | 0.08 | Why? |
| Tomography, X-Ray Computed | 4 | 2020 | 25144 | 0.08 | Why? |
| Laboratories | 1 | 2019 | 2858 | 0.08 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.08 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.07 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.07 | Why? |
| Paris | 2 | 2018 | 1287 | 0.06 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.06 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.06 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Incubators | 1 | 2019 | 3 | 0.05 | Why? |
| Prostaglandin-Endoperoxide Synthases | 1 | 1999 | 14 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.05 | Why? |
| Isoenzymes | 1 | 1999 | 127 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Achromobacter | 1 | 2018 | 4 | 0.05 | Why? |
| Burkholderia cepacia complex | 1 | 2018 | 18 | 0.05 | Why? |
| Anticoagulants | 2 | 2017 | 9563 | 0.05 | Why? |
| Neovascularization, Physiologic | 1 | 1999 | 160 | 0.05 | Why? |
| Calibration | 1 | 2019 | 307 | 0.05 | Why? |
| Urinary Retention | 1 | 2018 | 35 | 0.05 | Why? |
| Stenotrophomonas maltophilia | 1 | 2018 | 63 | 0.04 | Why? |
| Fertilization in Vitro | 1 | 2021 | 330 | 0.04 | Why? |
| Quinine | 1 | 2017 | 56 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Olfactory Bulb | 1 | 2020 | 333 | 0.04 | Why? |
| Urinary Bladder | 1 | 2018 | 170 | 0.04 | Why? |
| Probability | 1 | 2020 | 923 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.04 | Why? |
| Fungi | 1 | 2019 | 471 | 0.04 | Why? |
| Quality Control | 1 | 2019 | 628 | 0.04 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.04 | Why? |
| Metabolomics | 1 | 2021 | 921 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.03 | Why? |
| Vitamin K | 1 | 2017 | 263 | 0.03 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.03 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.03 | Why? |
| Environmental Microbiology | 1 | 2019 | 575 | 0.03 | Why? |
| Endocytosis | 1 | 2017 | 451 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.03 | Why? |
| Organ Specificity | 1 | 2017 | 1070 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.03 | Why? |
| Oncostatin M | 2 | 2003 | 17 | 0.03 | Why? |
| Blood Coagulation Tests | 1 | 2017 | 855 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Peptides | 2 | 2003 | 2513 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.03 | Why? |
| Smell | 1 | 2020 | 1851 | 0.03 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.03 | Why? |
| Bronchi | 1 | 2017 | 1048 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2018 | 1138 | 0.02 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Self Report | 1 | 2020 | 3802 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 1999 | 1751 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Health Care Surveys | 1 | 2018 | 2942 | 0.02 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Breast Neoplasms | 1 | 2003 | 3633 | 0.02 | Why? |
| Outpatients | 1 | 2017 | 3417 | 0.02 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Urokinase-Type Plasminogen Activator | 1 | 2003 | 62 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Coculture Techniques | 1 | 2003 | 258 | 0.02 | Why? |
| Matrix Metalloproteinases | 1 | 2003 | 131 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Specimen Handling | 1 | 2019 | 6190 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Nitrobenzenes | 1 | 1999 | 12 | 0.01 | Why? |
| Receptors, Urokinase Plasminogen Activator | 1 | 2003 | 252 | 0.01 | Why? |
| Cyclooxygenase Inhibitors | 1 | 1999 | 46 | 0.01 | Why? |
| Enzyme Induction | 1 | 1999 | 89 | 0.01 | Why? |
| Reference Values | 1 | 2003 | 795 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Cell Division | 1 | 1999 | 136 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Cyclooxygenase 2 Inhibitors | 1 | 1999 | 48 | 0.01 | Why? |
| Cyclooxygenase 2 | 1 | 1999 | 129 | 0.01 | Why? |
| Receptors, Cell Surface | 1 | 2003 | 586 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Blotting, Western | 1 | 1999 | 863 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Rabbits | 1 | 1999 | 1171 | 0.01 | Why? |
| Cell Movement | 1 | 1999 | 695 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Cornea | 1 | 1999 | 410 | 0.01 | Why? |
| Cell Line, Tumor | 1 | 2003 | 3608 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2003 | 2483 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Animals | 2 | 2017 | 78931 | 0.01 | Why? |
| Sulfonamides | 1 | 1999 | 1294 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 1454 | 0.01 | Why? |
| Membrane Proteins | 1 | 1999 | 1733 | 0.01 | Why? |
| Lung | 1 | 2017 | 31049 | 0.01 | Why? |
| Cells, Cultured | 1 | 1999 | 5835 | 0.01 | Why? |
| RNA, Messenger | 1 | 1999 | 5131 | 0.00 | Why? |